Myocardial remodeling in diabetic cardiomyopathy associated with cardiac mast cell activation.
Diabetic cardiomyopathy is a specific disease process distinct from coronary artery disease and hypertension. The disease features cardiac remodeling stimulated by hyperglycemia of the left ventricle wall and disrupts contractile functions. Cardiac mast cells may be activated by metabolic byproducts...
Guardado en:
Autores principales: | Zhi Gang Huang, Qun Jin, Min Fan, Xiao Liang Cong, Shu Fang Han, Hai Gao, Yi Shan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7e355c25b7a94109bd911544e73f0d38 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sacubitril/valsartan alleviates myocardial fibrosis in diabetic cardiomyopathy rats
por: Jiao Ai, et al.
Publicado: (2021) -
Haematopoietic and cardiac GPR55 synchronize post-myocardial infarction remodelling
por: Sarah-Lena Puhl, et al.
Publicado: (2021) -
Augmentation of myocardial If dysregulates calcium homeostasis and causes adverse cardiac remodeling
por: Pessah Yampolsky, et al.
Publicado: (2019) -
Yes-Associated Protein is Involved in Myocardial Fibrosis in Rats with Diabetic Cardiomyopathy
por: Hu M, et al.
Publicado: (2021) -
The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity
por: Qutuba G. Karwi, et al.
Publicado: (2021)